Citigroup’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,700	Closed	-$408K	–	6572
2020 Q4	$408K	Buy	15,700 +3,500	+29%	+$105K	﹤0.01%	4383
2020 Q3	$453K	Buy	12,200 +5,000	+69%	+$198K	﹤0.01%	3934
2020 Q2	$369K	Sell	7,200 -800	-10%	-$33.5K	﹤0.01%	4532
2020 Q1	$252K	Sell	8,000 -12,400	-61%	-$654K	﹤0.01%	4534
2019 Q4	$1.22M	Buy	20,400 +6,200	+44%	+$279K	﹤0.01%	3556
2019 Q3	$521K	Sell	14,200 -15,700	-53%	-$622K	﹤0.01%	4301
2019 Q2	$1.39M	Sell	29,900 -5,100	-15%	-$240K	﹤0.01%	3245
2019 Q1	$1.41M	Buy	35,000 +5,700	+19%	+$256K	﹤0.01%	3034
2018 Q4	$1.35M	Buy	29,300 +11,800	+67%	+$569K	﹤0.01%	3089
2018 Q3	$776K	Sell	17,500 -22,600	-56%	-$1.04M	﹤0.01%	3775
2018 Q2	$1.57M	Buy	40,100 +30,600	+322%	+$1.55M	﹤0.01%	2909
2018 Q1	$687K	Sell	9,500 -600	-6%	-$44.1K	﹤0.01%	3652
2017 Q4	$665K	Sell	10,100 -3,800	-27%	-$205K	﹤0.01%	3788
2017 Q3	$697K	Sell	13,900 -100	-0.7%	-$4.82K	﹤0.01%	3752
2017 Q2	$648K	Buy	14,000 +6,700	+92%	+$246K	﹤0.01%	3750
2017 Q1	$258K	Buy	7,300 +2,900	+66%	+$66.4K	﹤0.01%	4452
2016 Q4	$55K	Sell	4,400 -4,200	-49%	-$50K	﹤0.01%	6097
2016 Q3	$119K	Sell	8,600 -1,200	-12%	-$13.6K	﹤0.01%	5081
2016 Q2	$97K	Buy	9,800 +8,000	+444%	+$133K	﹤0.01%	5099
2016 Q1	$30K	Sell	1,800 -2,200	-55%	-$35.4K	﹤0.01%	6353
2015 Q4	$89K	Sell	4,000 -4,200	-51%	-$106K	﹤0.01%	5463
2015 Q3	$193K	Buy	+8,200	New	+$515K	﹤0.01%	4521